GermanyOther
Non-exclusive discount agreement for tocilizumab (PEN and FER) for 2026–2028
A non-exclusive rebate/discount agreement is being procured for the active substance tocilizumab, limited to the PEN and FER dosage forms, under Section 130a(8) SGB V for 2026-08-01 to 2028-07-31.
- Deadline
- 5 Jun 2028
- Published
- 16 Jun 2026
- CPV
- 33600000
Get help from a local consultant
Bidding cross-border? A Baltmodus consultant who works in this market can help you prepare and submit.
Find a consultant